Enlarged perivascular spaces and florbetapir uptake in patients with intracerebral hemorrhage

Eur J Nucl Med Mol Imaging. 2019 Oct;46(11):2339-2347. doi: 10.1007/s00259-019-04441-1. Epub 2019 Jul 29.

Abstract

Purpose: Enlarged perivascular spaces in the centrum semiovale (CSO-EPVS) have been linked to cerebral amyloid angiopathy (CAA). To get insight into the underlying mechanisms of this association, we investigated the relationship between amyloid-β deposition assessed by 18F-florbetapir PET and CSO-EPVS in patients with acute intracerebral hemorrhage (ICH).

Methods: We prospectively enrolled 18 patients with lobar ICH (suggesting CAA) and 20 with deep ICH (suggesting hypertensive angiopathy), who underwent brain MRI and 18F-florbetapir PET. EPVS were assessed on MRI using a validated 4-point visual rating scale in the centrum semiovale and the basal ganglia (BG-EPVS). PET images were visually assessed, blind to clinical and MRI data. We evaluated the association between florbetapir PET positivity and high degree (score> 2) of CSO-EPVS and BG-EPVS.

Results: High CSO-EPVS degree was more common in patients with lobar ICH than deep ICH (55.6% vs. 20.0%; p = 0.02). Eight (57.1%) patients with high CSO-EPVS degree had a positive florbetapir PET compared with 4 (16.7%) with low CSO-EPVS degree (p = 0.01). In contrast, prevalence of florbetapir PET positivity was similar between patients with high vs. low BG-EPVS. In multivariable analysis adjusted for age, hypertension, and MRI markers of CAA, florbetapir PET positivity (odds ratio (OR) 6.44, 95% confidence interval (CI) 1.32-38.93; p = 0.03) was independently associated with high CSO-EPVS degree.

Conclusions: Among patients with spontaneous ICH, high degree of CSO-EPVS but not BG-EPVS is associated with amyloid PET positivity. The findings provide further evidence that CSO-EPVS are markers of vascular amyloid burden that may be useful in diagnosing CAA.

Keywords: Amyloid PET; Cerebral amyloid angiopathy; Florbetapir; Intracerebral hemorrhage; Perivascular spaces.

Publication types

  • Clinical Trial

MeSH terms

  • Aged
  • Amyloid beta-Peptides / metabolism
  • Aniline Compounds / metabolism*
  • Cerebral Amyloid Angiopathy / diagnostic imaging*
  • Cerebral Hemorrhage / diagnostic imaging*
  • Ethylene Glycols / metabolism*
  • Female
  • Humans
  • Hypertension / radiotherapy
  • Magnetic Resonance Imaging
  • Male
  • Middle Aged
  • Multimodal Imaging
  • Multivariate Analysis
  • Positron-Emission Tomography
  • Prevalence
  • Prospective Studies

Substances

  • Amyloid beta-Peptides
  • Aniline Compounds
  • Ethylene Glycols
  • florbetapir